Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population

Código QR

Association analysis of the Cadherin13 gene with schizophrenia in the Japanese population

Ikuo Otsuka,1 Yuichiro Watanabe,2 Akitoyo Hishimoto,1 Shuken Boku,1 Kentaro Mouri,1 Kyoichi Shiroiwa,1 Satoshi Okazaki,1 Ayako Nunokawa,2 Osamu Shirakawa,3 Toshiyuki Someya,2 Ichiro Sora1 1Department of Psychiatry, Graduate School of Medicine, Kobe University, Kobe, 2Department of Psychiatry, Gradu...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Otsuka I, Watanabe Y, Hishimoto A, Boku S, Mouri K, Shiroiwa K, Okazaki S, Nunokawa A, Shirakawa O, Someya T, Sora I
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2015
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/5cc8c083707b4be09eb84e321d7108d1
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Association study of MIF promoter polymorphisms with suicide completers in the Japanese population
por: Shimmyo N, et al.
Publicado: (2017)

Investigation of chromosome Y loss in men with schizophrenia
por: Hirata T, et al.
Publicado: (2018)

A cross-sectional study exploring useful indicators for low bone mineral density in male alcoholic patients
por: Horai T, et al.
Publicado: (2018)

Association of Two Variable Number of Tandem Repeats in the Monoamine Oxidase A Gene Promoter with Schizophrenia
por: Tanifuji T, et al.
Publicado: (2021)

Early prediction of blonanserin response in Japanese patients with schizophrenia
por: Kishi T, et al.
Publicado: (2014)

Rare compound heterozygous missense SPATA7 variations and risk of schizophrenia; whole-exome sequencing in a consanguineous family with affected siblings, follow-up sequencing and a case-control study
por: Igeta H, et al.
Publicado: (2019)

Comparing the influences of age and disease on the Brief Assessment of Cognition in Schizophrenia in Japanese patients with schizophrenia
por: Kaneda A, et al.
Publicado: (2013)

Clozapine-induced seizures, electroencephalography abnormalities, and clinical responses in Japanese patients with schizophrenia
por: Kikuchi YS, et al.
Publicado: (2014)

Adherence and rehospitalizations in patients with schizophrenia: evidence from Japanese claims data
por: Kuwabara H, et al.
Publicado: (2015)

Help-seeking behavior among Japanese school students who self-harm: results from a self-report survey of 18,104 adolescents
por: Furukawa TA, et al.
Publicado: (2012)

Aberrant telomere length and mitochondrial DNA copy number in suicide completers
por: Ikuo Otsuka, et al.
Publicado: (2017)

Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials
por: Kishi T, et al.
Publicado: (2015)

Reversal of olanzapine-induced weight gain in a patient with schizophrenia by switching to asenapine: a case report
por: Okazaki K, et al.
Publicado: (2017)

Depression, Anxiety and Primiparity are Negatively Associated with Mother–Infant Bonding in Japanese Mothers
por: Motegi T, et al.
Publicado: (2020)

The cost of schizophrenia in Japan
por: Sado M, et al.
Publicado: (2013)

The relationship between insight and subjective experience in schizophrenia
por: Kako Y, et al.
Publicado: (2014)

Identification of Bonding Difficulties in the Peripartum Period Using the Mother-to-Infant Bonding Scale-Japanese Version and Its Tentative Cutoff Points
por: Hashijiri K, et al.
Publicado: (2021)

Comparative efficacy and safety of antipsychotics in the treatment of schizophrenia: a network meta-analysis in a Japanese population
por: Kishi T, et al.
Publicado: (2017)

Dietary patterns and schizophrenia: a comparison with healthy controls
por: Tsuruga K, et al.
Publicado: (2015)

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2016)

Atypical antipsychotics in the treatment of early-onset schizophrenia
por: Hrdlicka M, et al.
Publicado: (2015)

Long-Term Efficacy and Safety of Brexpiprazole in Elderly Japanese Patients with Schizophrenia: A Subgroup Analysis of an Open-Label Study
por: Inada K, et al.
Publicado: (2020)

Influence of patient characteristics on care time in patients hospitalized with schizophrenia
por: Sugibayashi Y, et al.
Publicado: (2014)

Pilot Validation Study of the Japanese Translation of the Brief Negative Symptoms Scale (BNSS)
por: Hashimoto N, et al.
Publicado: (2019)

Analysis of the cumulative effect of schizophrenia-related single nucleotide polymorphisms
por: Lozano R, et al.
Publicado: (2014)

An open-label study of algorithm-based treatment versus treatment-as-usual for patients with schizophrenia
por: Hirano J, et al.
Publicado: (2013)

Stimulus-dependent effects on right ear advantage in schizophrenia
por: Smucny J, et al.
Publicado: (2012)

Factor Structure and Measurement Invariance of the Hospital Anxiety and Depression Scale Across the Peripartum Period Among Pregnant Japanese Women
por: Ogawa M, et al.
Publicado: (2021)

Genetic association between G protein-coupled receptor kinase 6/β-arrestin 2 and dopamine supersensitivity psychosis in schizophrenia
por: Oda Y, et al.
Publicado: (2015)

Critical appraisal of lurasidone in the management of schizophrenia
por: Caccia S, et al.
Publicado: (2012)

Effect of triiodothyronine (T3) augmentation of acute milnacipran administration on monoamine levels: an in vivo microdialysis study in rats
por: Kitaichi Y, et al.
Publicado: (2012)

The social functional outcome of being naturalistically treated with paliperidone extended-release in patients with schizophrenia
por: Nakagawa R, et al.
Publicado: (2015)

Jumping to conclusions in schizophrenia
por: Evans SL, et al.
Publicado: (2015)

The relationship between self-disgust, guilt, and flow experience among Japanese undergraduates
por: Hirao K, et al.
Publicado: (2013)

Confirmation of the factorial structure of the Japanese short version of the TEMPS-A in psychiatric patients and general adults [Corrigendum]
por: Nakato Y, et al.
Publicado: (2017)

Predictive Utility of Body Mass Index for Metabolic Syndrome Among Patients with Schizophrenia in Japan
por: Sugawara N, et al.
Publicado: (2020)

Quality of life of patients with schizophrenia treated in foster home care and in outpatient treatment
por: Mihanović M, et al.
Publicado: (2015)

The utility of novel outcome measures in a naturalistic evaluation of schizophrenia treatment
por: Tompsett T, et al.
Publicado: (2018)

Japanese version of the Munich Parasomnia Screening: translation and linguistic validation of a screening instrument for parasomnias and nocturnal behaviors
por: Komada Y, et al.
Publicado: (2015)

Double-blind, comparative study of milnacipran and paroxetine in Japanese patients with major depression
por: Kamijima K, et al.
Publicado: (2013)